Healthcare
VioQuest Pharmaceuticals, Inc.(VOQP)
Live Price
Offline$0.003
+0.00% today
Window Change
+0.00%
Window
May 28, 2026 โ Jun 18, 2026
- Market Cap
- โ
- Revenue Growth
- 0.0%
- EPS Growth
- -12.0%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 16 bars ยท May 28, 2026 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
VioQuest Pharmaceuticals, Inc. (VOQP) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (May 28, 2026 โ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -12.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -12.0%, free cash flow -9.3% with operating margin 0.0% and ROIC -613.1%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VOQP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2006 was reported on Aug 11, 2006 with an EPS surprise of -66.7%.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -12.0%, with operating margin around 0.0%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VOQP
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
VOQP Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for VOQP and SPY.
Company Overview
VioQuest Pharmaceuticals, Inc.
Other OTC
VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products' lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.
- Leadership
- Mark D. Dacko
- IPO Date
- Apr 4, 1994
- Employees
- 3
- Street Address
- 180 Mount Airy Road
- Mailing
- Basking Ridge, NJ, 07920
- Region
- Basking Ridge, NJ, US
- Reporting Currency
- USD
- Investor Line
- 908-766-4455
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- -12.0%
- Free Cash Flow
- -9.3%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 1325.4%
- ROIC
- -613.1%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.22
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.